Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia (Q34420787)

2 August 2017

title

Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia (English)

1 reference

2 August 2017

1 reference

12

1 reference

2 August 2017

14

Hugues de Thé

0 references

Ali Bazarbachi

object named as

Ali Bazarbachi

15

0 references

Youmna Kfoury

10

object named as

Youmna Kfoury

1 reference

2 August 2017

9

Rihab Nasr

1 reference

2 August 2017

1

Hiba El Hajj

1 reference

2 August 2017

7

Anne Janin

1 reference

2 August 2017

5

Julien Ablain

1 reference

2 August 2017

2

Marwan El-Sabban

1 reference

2 August 2017

4

Ghazi Zaatari

1 reference

2 August 2017

8

Rami Mahfouz

1 reference

2 August 2017

Hideki Hasegawa

3

1 reference

2 August 2017

Shahrazad T Saab

6

1 reference

2 August 2017

Christophe Nicot

11

1 reference

2 August 2017

William Hall

13

1 reference

2 August 2017

language of work or name

English

0 references

publication date

6 December 2010

1 reference

Journal of Experimental Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

207

1 reference

2 August 2017

issue

13

1 reference

2 August 2017

page(s)

2785-2792

1 reference

Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Stem cell concepts renew cancer research

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Efficient tumour formation by single human melanoma cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

PML targeting eradicates quiescent leukaemia-initiating cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Mixed lineage leukemia translocations and a leukemia stem cell program

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

New therapeutic approaches for adult T-cell leukaemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

The core-binding factor leukemias: lessons learned from murine models

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Is human T-cell lymphotropic virus type I really silent?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

IFNalpha activates dormant haematopoietic stem cells in vivo.

6 July 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20101095

Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20101095

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20101095

Curing APL: differentiation or destruction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20101095

Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20101095

The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20101095

Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005222

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

27 October 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20101095

Therapeutic potential of arsenic trioxide with or without interferon-alpha for relapsed/refractory adult T-cell leukemia/lymphoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21135137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor growth need not be driven by rare cancer stem cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21135137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1084/JEM.20101095

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference